The functional loss of human natural killer cell activity induced by K562 is reversible via an interleukin-2-dependent mechanism
- 31 August 1986
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 101 (2), 558-570
- https://doi.org/10.1016/0008-8749(86)90166-8
Abstract
No abstract availableThis publication has 69 references indexed in Scilit:
- Cytolytic activity of purified cytoplasmic granules from cytotoxic rat large granular lymphocyte tumors.The Journal of Experimental Medicine, 1984
- Natural killer cells activated in a human mixed lymphocyte response culture identified by expression of Leu-11 and class II histocompatibility antigens.The Journal of Experimental Medicine, 1984
- Interleukin 2 enhances natural killing of normal lymphocytesCellular Immunology, 1984
- Studies on the mechanism of the human natural killer cell lethal hit: A new method for rapid physical isolation of lethally hit K562 targets and inhibition of cytolysis by reduced temperature or trypsinCellular Immunology, 1984
- Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.JCI Insight, 1983
- Antitumor reactivity in vitro and in vivo of lymphocytes from normal donors and cancer patients propagated in culture with T cell growth factor (TCGF)European Journal of Cancer and Clinical Oncology, 1983
- Cultures of purified human natural killer cells: Growth in the presence of interleukin 2Cellular Immunology, 1982
- Interferon‐Induced NK Augmentation in HumansScandinavian Journal of Immunology, 1981
- Natural killer cells are responsible for the interferon production induced in human lymphocytes by tumor cell contactEuropean Journal of Immunology, 1980
- Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation.The Journal of Experimental Medicine, 1978